» Articles » PMID: 17348457

Systematic Development of Clinical Practice Guidelines for Prostate Biopsies: a 3-year Italian Project

Overview
Journal Anticancer Res
Specialty Oncology
Date 2007 Mar 14
PMID 17348457
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The only available method to detect prostate cancer is prostate biopsy; however, to our knowledge, no evidence-based clinical practice guidelines have been established on this topic.

Materials And Methods: A three-year project was elaborated in which experts in the field worked to define the controversies existing in clinical practice regarding prostatic biopsies and then to develop guidelines by means of a systematic search of all the English-language literature using online databases and a consensus conference.

Results And Conclusion: The guidelines were formulated to help practitioners in making clinical decisions regarding the appropriate time the patient should undergo prostate biopsy, the type of antibiotic prophylaxis and anaesthesia, the biopsy approach, the method for processing and reporting prostatic needle cores, the biopsy technique, when to repeat a biopsy after a prior negative biopsy, radiotherapy or radical prostatectomy and the accuracy of biopsies in staging prostate cancer.

Citing Articles

Do longer or shorter cores yield more cancer?.

Hasan Y, Ozdal D World J Urol. 2018; 36(7):1179-1180.

PMID: 29704058 DOI: 10.1007/s00345-018-2304-9.


Are 10-, 10-12-, or > 12-mm prostate biopsy core quality control cutoffs reasonable?.

Sanches B, Lalli A, Azal Neto W, Billis A, Reis L World J Urol. 2018; 36(7):1055-1058.

PMID: 29497860 DOI: 10.1007/s00345-018-2242-6.


Longer biopsy cores do not increase prostate cancer detection rate: A large-scale cohort study refuting cut-off values indicated in the literature.

Yilmaz H, Yavuz U, Ustuner M, Ciftci S, Yasar H, Muezzinoglu B Turk J Urol. 2017; 43(3):297-302.

PMID: 28861301 PMC: 5562248. DOI: 10.5152/tud.2017.03743.


Is Prostate Biopsy Recommended in Turkish Men with a Prostate-Specific Antigen Level between 2.5 and 4 ng/mL?.

Koc G, Turk H, Karabicak M, Un S, Ergani B, Ekin R Curr Ther Res Clin Exp. 2017; 84():50-53.

PMID: 28761580 PMC: 5522978. DOI: 10.1016/j.curtheres.2017.04.003.


Length of prostate biopsies is not necessarily compromised by pooling multiple cores in one paraffin block: an observational study.

Tolonen T, Isola J, Kaipia A, Riikonen J, Koivusalo L, Huovinen S BMC Clin Pathol. 2015; 15:4.

PMID: 25810692 PMC: 4373419. DOI: 10.1186/s12907-015-0001-9.